New Data Implicate Components of Adaptive Immunity in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
New Data Implicate Components of Adaptive Immunity in Traumatic Brain Injury

SANTA BARBARA, Calif., Oct. 20, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences Inc., (OTCQB:VGLS) a biotechnology company, announces today that one of its scientific advisors, Dr. Richard Tobin, PhD, published data demonstrating that when there is traumatic brain injury (TBI), the body inflicts additional neural damage via the immune system. The data generated by Dr. Tobin shows immune therapy using VG Life Sciences' patented drug VG1177 can improve the condition.

This was published in the peer-reviewed Acta Neuropathologica Communications, which publishes experimental and descriptive articles on the pathology of nervous system and skeletal muscle disorders.

The title of the paper is "Traumatic brain injury causes selective, CD74-dependent, peripheral lymphocyte activation that exacerbates neurodegeneration," and can be found here .

TBI can vary in severity from a mild concussion to lifelong debilitation; however, these complications are not entirely the direct result of trauma, but rather complications resulting from immune activation. Neurological complications, such as swelling, lack of oxygen, and inflammation also contribute to the damage sustained from an initial insult.

Using a fluid-percussion injury model in mice, Dr. Tobin and the team demonstrated increased numbers of peripheral splenic lymphocytes, including CD4+ and CD8+ T cells, regulatory T cells, and gamma delta T-cells 24 hours following moderate TBI.

However, in mice lacking the MHC Class II invariant chain (CD74), fluid percussion injury was not associated with lymphocyte expansion nor with the degree of neuro-degeneration that occurs in the wild type mice.

Furthermore, wild type mice treated with VG1177 demonstrated similarly improved conditions as the CD74 deficient mice indicating a level of neuroprotection. VG1177 is targeted to remove displayed peptides from CD74.

"This research has important implications for contact sports involving all ages, military trauma, and accident victims," said Tobin. "We are encouraged that VG1177 may be an example of a new class of agents that affect the immune system to improve the outcome of traumatic brain injuries."

VG Life Sciences' patented drug, VG1177, is also undergoing pre-clinical animal safety trials at ITR Laboratories in Montreal, Canada.

Dr. Tobin is a post-doctoral fellow in the Texas A &M University laboratory of Dr. M. Karen Newell-Rogers, PhD, VG Life Sciences Inc.'s Chief Scientific Advisor and inventor of VG1177. The contributors to this paper include Sanjib Mukherjee, M.D., Ph.D., Jessica M. Kain, Susannah K. Rogers, Stephanie K. Henderson, Heather L. Motal, Lee A. Shapiro, Ph.D., and Dr. M. Karen. Newell Rogers.

About VG Life Sciences Inc.

Santa Barbara, California-based VG Life Sciences Inc. (OTCQB:VGLS), is a biotechnology company focused on discovering and developing drug therapies for cancer, infectious disease, and inflammatory, autoimmune disorders. VGLS controls over 40 US and international patents and pending patents protecting its exclusive biotech platform technologies.

For more information and upcoming events, visit www.vglifesciences.com or find VG Life Sciences Inc. on Facebook , Twitter , and LinkedIn .

Safe Harbor Statement and Forward-Looking Statements

This news release may contain forward-looking statements that involve risks and uncertainties associated with financial projections, milestone timelines, clinical development, regulatory approvals and other risks described by VG Life Sciences from time to time in its periodic reports. None of VG Life Sciences' drug compounds are approved by the US FDA or by any comparable regulatory agencies elsewhere in the world. Therefore, there can be no assurance that the forward-looking statements included in this release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the forward-looking statements should not be regarded as a representation by VG Life Sciences or any other person that the objectives and plans of VG Life Sciences will be achieved.

Allison Trabucco Corporate Communications VG Life Sciences Inc. Phone: (805) 879-9000 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AES Clears FERC, Nearing Its December 2 Takeover Close

Updated Category News Views 119

One more regulatory gate just swung open for AES, and this deal is finally staring at the finish line instead of wandering through the usual approval swamp. The Federal Energy Regulatory Commission has issued its final order approving AES's acquisition by a consortium led by Global Infrastructure Partners, part of BlackRock, and EQT Infrastructure VI. The last major...

Continue Reading
Floating Solar Gets a Serious Test in Central New York

Updated Category News Views 114

A flooded quarry pit outside Cortlandville is getting a second career, and that is more interesting than another solar announcement draped across empty acreage. Third Pillar Power has started construction on Crown City Solar at Suit-Kote Corporation's active Polkville Crushed Stone Facility, pairing a working mine, asphalt plant, and storage terminal with what the...

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 172

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 110

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading
Palm Beach Loan Company Tests Luxury Lending Demand

Updated Category News Views 103

Jewelry in a safe is dead capital until somebody lends against it. That plain fact sits behind Luxury Asset Capital's latest move: the launch of Palm Beach Loan Company, a South Florida brand aimed at wealthy owners of watches, diamonds, art, handbags, gold, collectibles, and other high-value possessions. The company is not asking clients to sell the stuff they spent...

Continue Reading
Finzly Welcomes Paul Finch to Drive BankOS Growth

Updated Category News Views 42

Finzly's Strategic Move to Boost Innovation Alright, folks, it seems Finzly means business. They just roped in Paul Finch, the brains who gave us Zelle during his stint as CEO over at Early Warning Services. This guy's been around the block with a couple of the biggest names in banking, and if his past headlines are any indicator, he's got the knack for shaking things up...

Continue Reading
Stand Out For Good Makes a Bold Michigan Avenue Bet

Updated Category News Views 183

A six-floor retail commitment lands with a thud Stand Out For Good is taking on roughly 51,079 square feet at 669 North Michigan Avenue, and nobody should mistake that for a casual expansion. Six levels on Chicago's Magnificent Mile is a proper declaration of intent, especially in a retail district that has endured plenty of empty-window handwringing and big-brand churn....

Continue Reading
Redseer's $5M Bet on Faster MENA Decision Intelligence

Updated Category News Views 7

Speed has become the expensive commodity in Middle Eastern commerce, and Redseer is putting roughly $5 million behind the idea that executives will pay to get it. Its newly launched Benchmarks MENA 2.0 platform combines proprietary market data with strategic advisory across nine MENA markets. That sounds like another corporate dashboard pitch until you consider the target...

Continue Reading
Skanska Adds $80M U.S. Tech Facility Contract to Orders

Updated Category News Views 29

An $80 million add-on is the sort of construction news that looks modest until you remember what it says about the customer relationship. Skanska has won an additional contract from an existing client for a U.S. tech facility, worth roughly SEK 760 million, and it will enter U.S. order bookings in the fourth quarter of 2026. No fireworks, no grand strategic...

Continue Reading
Madrigal Pharmaceuticals Faces Legal Scrutiny Over Data

Updated Category News Views 137

Legal Storm Brews for Madrigal Pharmaceuticals Watch out, here comes another storm for Madrigal Pharmaceuticals, folks. This ain't no small drizzle either; it's a full-on legal monsoon, and it's soaked straight through the walls of their executive suite. We're talking a whistleblower sending alarm bells ringing about data fudging and some dodgy boardroom maneuvers—as if...

Continue Reading

Top 5 Most Recently Viewed Articles

Recent Research Highlights the Distress of Captive Elephants

Updated Category News Views 249

Understanding the Distress of Elephants in Captivity A recent peer-reviewed study published in the journal Peer J has shed light on the overwhelming challenges that captive elephants continue to face within zoos despite ongoing efforts to improve conditions. This study stands as a significant testament to the struggles these majestic animals endure, raising essential...

Continue Reading
Exploring the Future of Paper-Based Biofuel Cells Industry

Updated Category News Views 119

Introduction to Paper-Based Biofuel Cells The paper-based biofuel cell (PBFC) market is on the verge of a significant transformation, expected to grow from a valuation of approximately US$ 385.29 million to over US$ 690.23 million by 2033. This remarkable growth reflects an annual growth rate of 7.56% as industries pivot increasingly towards sustainable energy solutions....

Continue Reading
AT&T and Ericsson Fly High with Drone Detection Demo

Updated Category News Views 72

Breaking Down the Drone Detection Demonstration The latest outing from AT&T and Ericsson isn't just tech eye candy—it's a dose of reality wrapped in tomorrow's promise. The goliath telecom duo pulled off a drone detection demo over 5G near AT&T Stadium in Arlington, Texas. What grabs headlines here isn't just the demonstration's success but how it smudges the line...

Continue Reading
Minerva University Launches Innovative Leadership Program in Tokyo

Updated Category News Views 196

Minerva University Launches Innovative Leadership Program The renowned Minerva University has introduced an exciting initiative designed to prepare global executives to effectively navigate today's complex world. The World Wise Executive Leadership Development Program, supported by the Nippon Foundation, focuses on developing leadership skills necessary for thriving in...

Continue Reading
Alpha Omega Partners with USDA to Boost Crop Insurance Support

Updated Category News Views 221

Alpha Omega Secures Contract with USDA to Enhance Crop Insurance Alpha Omega, a leader in digital modernization and cybersecurity, has landed a significant contract with the U.S. Department of Agriculture (USDA). This collaboration is set to enhance the USDA's crop insurance programs, which are essential for safeguarding farmers and ranchers against the growing challenges...

Continue Reading